A prospective, open label, multi-center, study of pregabalin in the treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, HIV-related peripheral neuropathic pain and chemotherapy induced peripheral neuropathic pain (pregabalin A0081097)

Trial Profile

A prospective, open label, multi-center, study of pregabalin in the treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, HIV-related peripheral neuropathic pain and chemotherapy induced peripheral neuropathic pain (pregabalin A0081097)

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Sep 2008 Actual patient number (121) added as reported by ClinicalTrials.gov.
    • 21 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Sep 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top